VLP Therapeutics Raises $16M in Series A Funding

23 Mar, 2021

VLP Therapeutics Raises $16M in Series A Funding
Photo by Kvnga on Unsplash

– VLP Therapeutics, Inc. is a biotech company based in Gaithersburg, MD.
– The company raised US$16m in Series A funding.
– Backers included MIYAKO Capital Co., Ltd., Sojitz Corporation, Konishiyasu Co., Ltd., in Japan and Mr. Robert G. Hisaoka, SK Impact Fund, LLC, and RJ Fund in USA.
– The new investment will be used for research and development of a cancer treatment vaccine, moving into clinical trials at the earliest date possible.

Biotechnology Health Care Medical Medical Device North America
Crunchbase icon

Content report

The following text will be sent to our editors: